Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Mortality associated with statins in men with advanced prostate cancer treated with androgen deprivation therapy.

Wu SY, Fang SC, Shih HJ, Wen YC, Shao YJ.

Eur J Cancer. 2019 May;112:109-117. doi: 10.1016/j.ejca.2018.11.032. Epub 2019 Feb 28.

PMID:
30827745
2.

The impact of statins in combination with androgen deprivation therapyin patients with advanced prostate cancer: A large observational study.

Anderson-Carter I, Posielski N, Liou JI, Khemees TA, Downs TM, Abel EJ, Jarrard DF, Richards KA.

Urol Oncol. 2019 Feb;37(2):130-137. doi: 10.1016/j.urolonc.2018.11.017. Epub 2018 Dec 7.

PMID:
30528885
3.

Statin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients With Hormone-Sensitive Prostate Cancer.

Harshman LC, Wang X, Nakabayashi M, Xie W, Valenca L, Werner L, Yu Y, Kantoff AM, Sweeney CJ, Mucci LA, Pomerantz M, Lee GS, Kantoff PW.

JAMA Oncol. 2015 Jul;1(4):495-504. doi: 10.1001/jamaoncol.2015.0829. Erratum in: JAMA Oncol. 2015 Jul;1(4):544.

4.

Associations between statin use and progression in men with prostate cancer treated with primary androgen deprivation therapy.

Mikkelsen MK, Thomsen FB, Berg KD, Jarden M, Larsen SB, Hansen RB, Brasso K.

Scand J Urol. 2017 Dec;51(6):464-469. doi: 10.1080/21681805.2017.1362032. Epub 2017 Aug 23.

PMID:
28831860
5.

Androgen deprivation therapy and the risk of death from prostate cancer among men with favorable or unfavorable intermediate-risk disease.

Keane FK, Chen MH, Zhang D, Moran BJ, Braccioforte MH, D'Amico AV.

Cancer. 2015 Aug 15;121(16):2713-9. doi: 10.1002/cncr.29420. Epub 2015 Apr 29.

6.

Short-course androgen deprivation therapy and the risk of death from high-risk prostate cancer in men undergoing external beam radiation therapy and brachytherapy.

Raldow AC, Zhang D, Chen MH, Braccioforte MH, Moran BJ, D'Amico AV.

Brachytherapy. 2015 Nov-Dec;14(6):781-7. doi: 10.1016/j.brachy.2015.08.004. Epub 2015 Sep 9.

PMID:
26361718
7.

Prostate cancer survival among statin users after prostatectomy in a Finnish nationwide cohort.

Joentausta RM, Rannikko A, Murtola TJ.

Prostate. 2019 May;79(6):583-591. doi: 10.1002/pros.23768. Epub 2019 Jan 16.

PMID:
30652328
8.

Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Lozano P, Henrikson NB, Dunn J, Morrison CC, Nguyen M, Blasi PR, Anderson ML, Whitlock E.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Aug.

9.

Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer.

Murtola TJ, Peltomaa AI, Talala K, Määttänen L, Taari K, Tammela TLJ, Auvinen A.

Eur Urol Focus. 2017 Apr;3(2-3):212-220. doi: 10.1016/j.euf.2016.05.004. Epub 2016 Jun 2.

PMID:
28753762
10.

Prostate cancer-specific mortality after definitive radiation therapy: who dies of disease?

Kim MM, Hoffman KE, Levy LB, Frank SJ, Pugh TJ, Choi S, Nguyen QN, McGuire SE, Lee AK, Kuban DA.

Eur J Cancer. 2012 Jul;48(11):1664-71. doi: 10.1016/j.ejca.2012.01.026. Epub 2012 Feb 13.

PMID:
22336663
11.

Prostate-Specific Antigen-Based Screening for Prostate Cancer: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Fenton JJ, Weyrich MS, Durbin S, Liu Y, Bang H, Melnikow J.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 May.

12.

Short-term androgen-deprivation therapy improves prostate cancer-specific mortality in intermediate-risk prostate cancer patients undergoing dose-escalated external beam radiation therapy.

Zumsteg ZS, Spratt DE, Pei X, Yamada Y, Kalikstein A, Kuk D, Zhang Z, Zelefsky MJ.

Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):1012-7. doi: 10.1016/j.ijrobp.2012.07.2374. Epub 2012 Sep 14.

PMID:
22981709
13.

Statin use and mortality of patients with prostate cancer: a meta-analysis.

Meng Y, Liao YB, Xu P, Wei WR, Wang J.

Onco Targets Ther. 2016 Mar 21;9:1689-96. doi: 10.2147/OTT.S97993. eCollection 2016.

14.

Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy.

Jackson WC, Schipper MJ, Johnson SB, Foster C, Li D, Sandler HM, Palapattu GS, Hamstra DA, Feng FY.

Eur Urol. 2016 Jan;69(1):50-7. doi: 10.1016/j.eururo.2015.05.009. Epub 2015 May 21.

PMID:
26004800
15.

Race and mortality risk after radiation therapy in men treated with or without androgen-suppression therapy for favorable-risk prostate cancer.

Kovtun KA, Chen MH, Braccioforte MH, Moran BJ, D'Amico AV.

Cancer. 2016 Dec 1;122(23):3608-3614. doi: 10.1002/cncr.30224. Epub 2016 Aug 4.

16.

Androgen Deprivation Therapy Use in the Setting of High-dose Radiation Therapy and the Risk of Prostate Cancer-Specific Mortality Stratified by the Extent of Competing Mortality.

Rose BS, Chen MH, Wu J, Braccioforte MH, Moran BJ, Doseretz DE, Katin MJ, Ross RH, Salenius SA, D'Amico AV.

Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):778-784. doi: 10.1016/j.ijrobp.2016.08.014. Epub 2016 Aug 22.

PMID:
27788950
17.

Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database.

Keto CJ, Aronson WJ, Terris MK, Presti JC, Kane CJ, Amling CL, Freedland SJ.

BJU Int. 2012 Aug;110(4):492-8. doi: 10.1111/j.1464-410X.2011.10754.x. Epub 2011 Nov 17.

18.

Early Versus Delayed Initiation of Salvage Androgen Deprivation Therapy and Risk of Prostate Cancer-Specific Mortality.

Mahal BA, Chen MH, Renshaw AA, Loffredo MJ, Kantoff PW, D'Amico AV.

J Natl Compr Canc Netw. 2018 Jun;16(6):727-734. doi: 10.6004/jnccn.2018.7010.

PMID:
29891524
19.

Prostate cancer incidence and mortality among men using statins and non-statin lipid-lowering medications.

Van Rompay MI, Solomon KR, Nickel JC, Ranganathan G, Kantoff PW, McKinlay JB.

Eur J Cancer. 2019 May;112:118-126. doi: 10.1016/j.ejca.2018.11.033. Epub 2019 Mar 6.

PMID:
30850323
20.

Influence of Statins and Cholesterol on Mortality Among Patients With Pancreatic Cancer.

Huang BZ, Chang JI, Li E, Xiang AH, Wu BU.

J Natl Cancer Inst. 2016 Dec 31;109(5). doi: 10.1093/jnci/djw275. Print 2017 May.

PMID:
28040693

Supplemental Content

Support Center